Journal article · 2024 · Open access

Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

Fulden Sarı, Zilan Bazancir‐Apaydin, Hakan Apaydın, Mehmet Kayaalp, Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Küçükşahin, Şükran Erten

Archives of Rheumatology, 39(1), 052–059 · Published 31 March 2024 · DOI 10.46497/archrheumatol.2023.10183

Open full textCite this paper

In brief

“Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis” is a 2024 journal article by Fulden Sarı and 9 co-authors, published in Archives of Rheumatology. OpenAlex counts 2 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Archives of Rheumatology.

Citations
2
Most cited in
2024 (1)
Field-weighted impact
0.44
References
21
Authors
10

Abstract

Objectives: This study aimed to translate the Scleroderma Skin Patient-Reported Outcome (SSPRO) questionnaire to the Turkish (SSPRO-T) language and to assess its validity and reliability. Patients and methods: Fifty-four systemic sclerosis (SSc) patients (51 females, 3 males; mean age: 49.8±10.4 years; range, 22 to 65 years) participated in the reliability and validity analysis between October 2022 and December 2022. The translation and cross-cultural adaptation of the SSPRO-T was applied in accordance with the procedure described by the Beaton guidelines. The SSPRO-T, the Scleroderma Health Assessment Questionnaire (SHAQ), the Health Assessment Questionnaire Disability Index (HAQ-DI), Skindex-29, and patient global skin severity were conducted in all participants for construct validity. The SSPRO-T was retested to assess its reliability after seven days. Results: The SSPRO-T had a four-factor structure. The total SSPRO-T score and its subgroups correlated positively with SHAQ, HAQ-DI, Skindex-29, and patient global skin severity. The internal consistency and reliability were excellent in overall SSPRO-T and in the subgroups: physical effect, emotional effect, physical limitation, and social effect (Cronbach's α=0.94, 0.80, 0.95, 0.93, and 0.84, respectively). The SSPRO-T had excellent test-retest reliability (r=0.91, p<0.001). In addition, no floor effect or ceiling effect was observed. Conclusion: The SSPRO-T questionnaire is a reliable and valid tool and can be used in research and clinical practice in Turkish patients with SSc.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sarı, F., Bazancir‐Apaydin, Z., Apaydın, H., Kayaalp, M., Erden, A., Güven, S. C., Armağan, B., Omma, A., Küçükşahin, O., & Erten, Ş. (2024). Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis. Archives of Rheumatology, 39(1), 052–059. https://doi.org/10.46497/archrheumatol.2023.10183

MLA 9

Sarı, Fulden, et al. “Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis.” Archives of Rheumatology, vol. 39, no. 1, 2024, pp. 052–059. https://doi.org/10.46497/archrheumatol.2023.10183.

Chicago

Sarı, Fulden, Zilan Bazancir‐Apaydin, Hakan Apaydın, Mehmet Kayaalp, Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Küçükşahin, and Şükran Erten. 2024. “Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis.” Archives of Rheumatology 39 (1): 052–059. https://doi.org/10.46497/archrheumatol.2023.10183.

Harvard

Sarı, F. et al. (2024) ‘Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis’, Archives of Rheumatology, 39(1), pp. 052–059. doi:10.46497/archrheumatol.2023.10183.

IEEE

F. Sarı et al., “Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis,” Archives of Rheumatology, vol. 39, no. 1, pp. 052–059, 2024, doi: 10.46497/archrheumatol.2023.10183.

BibTeX

@article{sar2024reliability,
  title     = {{Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis}},
  author    = {Sarı, Fulden and Bazancir‐Apaydin, Zilan and Apaydın, Hakan and Kayaalp, Mehmet and Erden, Abdülsamet and Güven, Serdar Can and Armağan, Berkan and Omma, Ahmet and Küçükşahin, Orhan and Erten, Şükran},
  journal   = {Archives of Rheumatology},
  year      = {2024},
  volume    = {39},
  number    = {1},
  pages     = {052--059},
  doi       = {10.46497/archrheumatol.2023.10183},
  url       = {https://doi.org/10.46497/archrheumatol.2023.10183}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases

  • systemic sclerosis
  • Turkish translation
  • cross-cultural adaptation
  • patient-reported outcome measures
  • skin involvement
  • construct validity
  • test-retest reliability
  • psychometric properties

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Sarı, F., Bazancir‐Apaydin, Z., Apaydın, H., Kayaalp, M., Erden, A., Güven, S. C., Armağan, B., Omma, A., Küçükşahin, O., & Erten, Ş. (2024). Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis. Archives of Rheumatology, 39(1), 052–059. https://doi.org/10.46497/archrheumatol.2023.10183

How many times has this paper been cited?

2 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Archives of Rheumatology: sign in and open the full text from this page.

Who wrote this paper?

Fulden Sarı, Zilan Bazancir‐Apaydin, Hakan Apaydın, Mehmet Kayaalp, Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Küçükşahin, Şükran Erten.

What is the DOI of this paper?

10.46497/archrheumatol.2023.10183, permanently at https://doi.org/10.46497/archrheumatol.2023.10183. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.